Vicore Pharma postpones publication of interim report

2018-09-26 | Regulatory

Mölndal, September 26, 2018 – Vicore Pharma Holding AB (publ) has decided to postpone the publication of the interim report for the third quarter 2018. The interim report will be published on November 8, 2018, instead of previously announced October 19, 2018.

For further information, please contact:

Dr. Carl-Johan Dalsgaard, CEO: +46 709 759 863, carl-johan.dalsgaard@vicorepharma.com